Objective To analyze the epidemic characteristics of drug-resistant tuberculosis (TB) among students, so as to provide evidence for optimizing disease prevention and control measures. Methods The data were obtained from cases of drug-resistant TB in students registered in Tuberculosis Management Information System of China Information System for Disease Control and Prevention from 2016 to 2020. Descriptive epidemiological methods were used to analyze the gender, age, nationality, treatment and prognosis of the patients with drug-resistant TB. Results A total of 2 541 cases of drug-resistant TB were registered in students from 2016 to 2020, in whom 2 469 (97.17%) were patients resistant to rifampin. Of the registered patients, 1 395 (54.90%) were males, and 1 146 (45.10%) females. 2 174 (85.56%) cases were Han nationality, and 367 (14.44%) minorities. The median age was 18 (17, 20) years old, and the infection was most seen in students aged 19 or over, accounting for 1 206(47.46%), followed by those aged 16-18 years (946, 37.23%). Patients aged from 0 to 12 years were least seen (only 68 cases, 2.68%). The registered cases were the highest in the western area (906 cases, 35.65%), while the registered cases were minimal in the central area of China (810 cases, 31.88%). By treatment, patients just underwent initial medication, which accounted for 73.55%. The proportion of patients with single rifampicin resistance and multi-drug resistance, from minority, aged between 0 and 19, and those undergone first medication tended to increase year by year (χ2trend=206.016, 18.212, 17.433, 45.651, all P<0.01). Overall treatment initiation rate of rifampicin-resistant patients was 91.58% (2 261/2 469), respectively 81.04% (171/211), 85.06% (279/328), 89.77% (500/557), 94.84% (662/698)and 96.15% (649/675) from 2016 to 2020, which showed an upward trend annually (χ2trend=75.340, P<0.01). 74.48% (1 684/2 261) of the patients were successfully treated. The successful medication rate was the highest in patients aged 16-18 years (77.62%) and in the eastern area, and the lowest in those aged 0-12(59.38%) and in the central area. The difference was significant in diverse age group (χ2=13.608, P<0.01) and different areas (χ2=10.240, P<0.01). The highest success rate of treatment was seen in the patients registered in between 2017 and 2018, which was 77.06% and 77.00%, respectively, and the lowest was seen in those registered in 2016, which was 66.67%. The difference was significant regarding the successfully medication rate in patients registered in different years (χ2=9.974, P<0.05). The successful medication rate was the highest in local residents, and the lowest in population floating among cities (81.04% vs. 57.62%, χ2=226.854, P<0.01). Conclusion From 2016 to 2020, the number of drug-resistant pulmonary tuberculosis cases detected among students has increased, and the prevention and control efforts has arrived at certain level, yet certain issues still exist. Although the treatment rate and successful medication rate appear higher, yet attention should be paid to the patients with missed therapy or poor prognosis. Therefore, it is suggested to strengthen screening, improve detection quality and strengthen the cooperation between schools, CDC and medical institutions.